Company Filing History:
Years Active: 2016-2025
Title: Amanda Aileen Willis: Innovator in Injectable Pharmaceutical Compositions
Introduction
Amanda Aileen Willis is a notable inventor based in New South Wales, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions. With a total of 3 patents to her name, her work focuses on enhancing the efficacy and safety of drug formulations.
Latest Patents
One of Amanda's latest patents involves injectable pharmaceutical compositions that comprise a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative. This innovative formulation includes one or more water-soluble complexes, each consisting of a cyclodextrin or a cyclodextrin derivative combined with a hydrophobic drug. The compositions are designed to be effectively preserved according to the European Pharmacopoeia 2011 Test for Efficacy of Antimicrobial Preservation, meeting at least the B criteria for parenterals. Additionally, they satisfy the United States Pharmacopeia 2011 Guidelines for Antimicrobial Effectiveness Testing, fulfilling the criteria for Category 1 (injectable) products.
Career Highlights
Throughout her career, Amanda has worked with reputable companies such as Jurox Pty Ltd and Zoetis Services LLC. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in pharmaceutical technology.
Collaborations
Amanda has collaborated with professionals like Kirby Shawn Pasloske and Sarah Jane Richardson, further enhancing her innovative projects and expanding her impact in the industry.
Conclusion
Amanda Aileen Willis stands out as a pioneering inventor in the field of injectable pharmaceutical compositions. Her contributions are vital to the ongoing development of safe and effective drug formulations.